Compare
Ventricular Assist Devices (VADs)

Functional
Generations 4 & 5

- Over 440 implants worldwide of the MicroMed VAD account for more than 130 patient years of life
- CE approved Pediatric VAD · CE approved Adult VAD

About MicroMed Cardiovascular, Inc.

Ray Bernal
Director

Ray Bernal joined the MicroMed board in January 2010. Mr. Bernal retired as Vice President from Valley National Bank of Arizona in 1992 where he managed and served as credit administrator for various commercial loan departments. He serves as a U.S. Bankruptcy Trustee and owns two operating businesses. Mr. Bernal holds a B.S. degree in Agricultural Economics from the University of Arizona and graduated with distinction from the Southwestern Graduate School of Banking at SMU.

Norwick B.H. Goodspeed
Director

Norwick B.H. Goodspeed has served as a director of MicroMed Cardiovascular, Inc. since March 2003. Mr. Goodspeed is President and Chief Executive Officer of FlowCardia, Inc., where he has served since March 2004. From May 2000 to January 2004, he was President and Chief Executive Officer of TransVascular, Inc., an interventional cardiology company acquired by Medtronic, Inc. in September 2003. From June 1997 to May 2000, he was President and Chief Executive Officer of Ocular Sciences, a publicly traded contact lens manufacturer. Previously, Mr. Goodspeed served as President of McGaw Inc. (a manufacturer of I.V. Solutions and a subsidiary of Ivax) and President and Chief Executive Officer of Vical, Inc. (a gene therapy company). Earlier in his career, Mr. Goodspeed held executive positions with BOC Healthcare and Baxter. He holds an M.B.A. degree from Stanford University and a B.A. from Yale University.

Rodger G. Ford
Director

Rodger Ford joined the board of directors for MicroMed Cardiovascular in July 2008. Since August 2005, Mr. Ford has been the CEO and president of SynCardia Systems, Inc. and a director of SynCardia since May 2004. SynCardia manufactures the CardioWest™ temporary Total Artificial Heart and is currently developing a family of pulsatile ventricular assist devices.

Mr. Ford brings more than 35 years of entrepreneurial accomplishments and leadership to the MicroMed board of directors, having founded AlphaGraphics Print Shops of the Future in the 1970s.Under Mr. Ford’s leadership, AlphaGraphics grew to more than 400 locations worldwide, with operations in Canada, South America, Australia, Europe and the Middle East. He also formed Anthem Equity Group, Inc. in 1991. Anthem Equity Group is a significant owner and operator of commercial real estate in Southern Arizona. Mr. Ford has served on boards of numerous public and private organizations and was named an Ernst & Young Entrepreneur of the Year in 2000. Mr. Ford holds a B.S. degree in accounting from Brigham Young University and an M.B.A. from the University of Arizona.

J. David Mackstaller
Director

J. David Mackstaller joined the board of directors for MicroMed Cardiovascular in July 2008. Since March 2005, Mr. Mackstaller has been the Vice President of Sales, Marketing and Corporate Development for SynCardia Systems, Inc., and a member of SynCardia’s board of directors since September 2005. SynCardia manufactures the CardioWest™ temporary Total Artificial Heart and is currently developing a family of pulsatile ventricular assist devices.

Mr. Mackstaller brings a lifetime of business experience to the board of directors for MicroMed. In 1973, he co-founded the Schomac Group of companies, a developer and operator of real estate projects from coast to coast having a cumulative value of more than $300 million. In 1991, Mr. Mackstaller joined Mr. Ford to form Anthem Equity Group, Inc., a significant owner and operator of commercial real estate in Southern Arizona. Mr. Mackstaller was named an Ernst & Young Entrepreneur of the Year in 2000. Mr. Mackstaller holds a B.A. degree in economics from the University of Michigan and a Juris Doctorate from the University of Michigan Law School.

Bill Birdsall
Chief Executive Officer and Chairman

Bill Birdsall joined MicroMed in October 2008 as Chief Executive Officer and Chairman. Mr. Birdsall is an attorney with a successful career of starting and building businesses. In the 1970’s he played a significant role in the establishment of Ticketmaster, Inc., where he was founding Executive Vice President and built the company into a world leader in the entertainment industry. Mr. Birdsall has also been a pioneer in the public real estate markets. He was Chairman of the Board of Host Funding, Inc., a public real estate investment company listed on the NASDAQ stock exchange and Chairman of the Board and CEO of The Price REIT, a New York Stock Exchange company he co-founded in 1991 with retailer Sol Price. He is also a founding director and major shareholder of Sub-Crypto systems, a software firm providing digital security systems to military and corporate clients. He has served as legal counsel to the Interior Committee of the U.S. House of Representatives and to the Joint House and Senate Oversight Committee for the Office of Technology Assessment, as well as Assistant Attorney General for the State of Arizona. Mr. Birdsall is a graduate of the University of Arizona Law School and a member of the Arizona and Colorado Bar Associations.

Sailesh Saxena
Chief Financial Officer

Sailesh Saxena joined MicroMed in March 2010. He has been helping MicroMed as a Financial Consultant since September 2009. Mr. Saxena has over twenty years of consulting and leadership experience, in the areas of financial services, supply chain, information technology, research & development and operations. Prior to this, Mr. Saxena has worked with numerous private equity fund companies, like Matador Capital partners, Wright Capital, USGT Investors LP, Trinity Private Equity, in providing financial consulting and analysis on transactions to raise capital for potential acquisitions. Prior to this, Mr. Saxena worked for WMS software provider, Optum, where he held various management positions. Mr. Saxena holds a B.S in Electrical and Electronics engineering from Birla Institute of Technology & Science (BITS), Pilani, India and an MBA from SMU Cox School of Business with specialization in finance. He is a member of Beta Gamma Sigma honor society.

Bryan E. Lynch
Chief Operating Officer

Bryan Lynch joined MicroMed in July 1997 as Director of Operations and he became Vice President of Operations in May 2001, then Vice President of International Sales and Marketing in January of 2005 and Chief Operating Officer in June 2010.  Previously, he served as director of marketing and product development with Komet Medical, Inc., a German manufacturer and distributor of surgical instruments and hard tissue cutting systems. From 1990 to 1994, Mr. Lynch served as manager of engineering, research and development for Surgimedics, Inc., a Texas-based medical device company, developing products for minimally invasive surgery, laser surgery and autologous blood transfusion.  Mr. Lynch is co-inventor of several patents including pulsatile loop and implantable pump patents at MicroMed.  Mr. Lynch holds a B.S. in Mechanical Engineering from Texas Tech University and an M.B.A. from Texas Christian University.

Jay Kraemer
Vice President of Sales & Marketing

Jay Kraemer joined MicroMed in February 2010. He has 27 years of sales, sales management and business development experience in the pharmaceutical, biotech, implantable medical device and medical capital equipment areas where he and his sales and clinical teams won numerous awards for exemplary sales performance and customer service. Previously, Mr. Kraemer was a Region Sales Director for InTouch Health Technologies, a Company focused on the use of remote presence robotics in telemedicine in providing specialized medical care to patients in rural areas. Prior to that Mr. Kraemer served as a Regional Vice President for GE Healthcare leading a Sales Team responsible for $75M per year in revenue in diagnostic imaging equipment. Prior to that Mr. Kraemer spent 17 years in several positions of increasing sales management responsibility at Medtronic in both the Neurological and Cardiac Rhythm Management businesses. He was part of the original team that launched the first transvenous, tiered-therapy defibrillation systems in the industry. He was also Director of National Account Development at Medtronic Neurological where he lead efforts to drive new business with Executive Administration of several large National Health Systems in the U.S. Prior to Medtronic, Mr. Kraemer spent 3 years at Genentech Inc. where he was part of their first direct Sales Team that launched rt-PA, a Clot Buster for acute myocardial infarctions. Prior to that, Mr. Kraemer spent 5 years as a Senior Professional Sales Representative for Merck & Co., Inc. where he successfully sold musculoskeletal, ophthalmic and anti-infective office-based and hospital product lines. Mr. Kraemer holds a B.S. in Business Administration from Minnesota State University.   

Contact Us